Katherine Steinberg, MPP, MBA Joins the Avalere Center for Payment and Delivery Innovation™
Katherine Steinberg comes to Avalere Health with more than 15 years’ experience in the healthcare arena.
Outpatient Services Are the Largest Driver of 2017 Premium Increases
Prescription drugs are not outsized contributors to rate increases.
Most Health Plans Do Not Use Existing Value Frameworks to Make Coverage Decisions
The plans are waiting to see how frameworks will evolve and if physicians embrace them before relying on them to decide which prescription drugs to cover.
E2 – What the Elections Might Mean for the Drug Pricing Debate
Our experts provide a quick glimpse into the role healthcare will play in the 2016 elections and hot topics you can expect to hear about on the campaign trail.
Leading Stakeholders Identify Need for Tools to Manage Post-Acute Network Quality
Data show gaps in care integration across provider settings following hospital discharges.
UPDATE: Early Analysis Finds 2017 Proposed Exchange Premiums for Low Cost Silver Plans Increasing 8 Percent on Average
Rates vary widely by state; popular low cost options see smaller increases.
An Overview of FDA’s Expanded Access Guidances
Our expert, Jay Jackson, discusses recent final guidance issued by the FDA on compassionate use.
Avalere Welcomes Senior Healthcare Advisor
Wendy Everett, ScD, joins Avalere as a senior advisor.
Snapshot of Gubernatorial Elections and Outlooks
Recently, Avalere took a look at the gubernatorial elections happening this year, their outlooks, and where they stand on the Exchanges and the Medicaid expansion.
Providers Across the US Express Interest in Moving to New Cancer Payment Model to Control Medicare Costs
Earlier today, the Centers for Medicare and Medicaid Services (CMS) released participation information for its new Oncology Care Model (OCM) slated to begin July 1.
New Alignments in Data-Driven Care Coordination and Access for Specialty Products
Recently we examined the various models of specialty pharmacy integration/ownership and how they result in different care coordination dynamics and access to drugs. Our findings demonstrate real value and opportunities in linking medical and pharmacy data to better support the patient journey with services and tools.
E1 – An Introduction to the 2016 Election Series
Between now and November, Avalere will to bring election content to the public dialogue. Our experts provide a glimpse into the role healthcare will play in the 2016 elections and hot topics you can expect to hear about on the campaign trail.
Performance-Based Risk-Sharing Arrangements: What Are the Views from the Negotiating Table?
Shifting to a value-based purchasing (VBP) system provides opportunities to engage payer and provider customers in unique contracting and reimbursement relationships that may optimize market access.
Health Plans Are Interested in Tying Drug Payments to Patient Outcomes
Hepatitis C and Oncology Are Top Therapeutic Area Targets
Costs of Care: Getting the Patient-Clinician Conversation Right
Avalere Supports the Robert Wood Johnson Foundation in Issuing Two Calls for Proposals
MedPAC Proposes Changes for 42 Million Medicare Beneficiaries Enrolled in Part D
Cost-sharing changes could increase costs for many beneficiaries.
Commercial Uncertainty Remains as US Biosimilar Pipeline Matures
With the recent announcement of the U.S. Food and Drug Administration's (FDA) acceptance of a submission for approval of a second biosimilar to Remicade (infliximab), questions remain for biologics manufacturers, payers, prescribers, and others as to how a mature biosimilars pipeline will begin to evolve in the United States and whether a sustainable competitive specialty market will develop.
Key Takeaways from the FasterCures Value Assessment 2.0 Webinar
On June 1, Josh Seidman participated in a panel discussion hosted by FasterCures to discuss Avalere's collaboration with FasterCures to develop a patient-centric value framework.
CORRECTION: Early Analysis Finds 2017 Proposed Exchange Rates Exceed 2016 Increases But Vary Widely By State
Popular low cost options see smaller increases.
Side-by-Side Comparison of Clinton and Trump’s Healthcare Priorities
As we near the July conventions and the November election, the dialogue continues to ramp up on the latest policy proposals from the presumptive presidential nominees - Hillary Clinton and Donald Trump.